Results 121 to 130 of about 714,950 (305)

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Should We Proscribe Existential There

open access: yesDiscourse and Writing/Rédactologie, 1996
Lilita Rodman
doaj   +1 more source

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

The Practices of Technical Writing: Bridging the Culture Gaps

open access: yesDiscourse and Writing/Rédactologie, 1995
Michael P. Jordan
doaj   +1 more source

Teaching games for understanding in school handball: a controlled pre-post study with intact Brazilian physical education classes. [PDF]

open access: yesFront Psychol
Silva RMO   +10 more
europepmc   +1 more source

Access to Writing Kit for Engineering Design Reports

open access: yes, 2017
The “Writing Kit for Engineering Design Reports” is a suite of tools designed to support the development of improved technical writing skills in undergraduate engineering students.
Pritchard, Peggy A.   +3 more
core  

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Technical Writing

open access: yesPhysics Bulletin, 1964
openaire   +2 more sources

Using Acronyms in Technical Writing

open access: yesDiscourse and Writing/Rédactologie, 1999
Michael P. Jordan
doaj   +1 more source

Home - About - Disclaimer - Privacy